< Back to all Breaking News
CRIS
9/11/2017 06:09am
Curis, Aurigene announce plans to initiate Phase 2 trial of CA-170 in India
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.